Approval · Notice of Compliance 1097 · 2000
SOLARASE: Notice of Compliance 1097
Issued August 17, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1097
- Date
- August 17, 2000
- Company
- Skyepharma Inc.Parsippany, New Jersey, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Treatment of actinic keratoses
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SOLARASE | 02238019 | — |
Medicinal ingredients
- DICLOFENAC SODIUM 3 PER